Cargando…
CALCA and TRPV1 genes polymorphisms are related to a good outcome in female chronic migraine patients treated with OnabotulinumtoxinA
BACKGROUND: Some variables have been proposed as predictors of efficacy of OnabotulinumtoxinA in chronic migraine patients, but data available are inconclusive. We aimed to analyse the influence of single nucleotide polymorphisms in the response to OnabotulinumtoxinA. METHODS: We included 156 female...
Autores principales: | Moreno-Mayordomo, R., Ruiz, M., Pascual, J., Gallego de la Sacristana, M., Vidriales, I., Sobrado, M., Cernuda-Morollon, E., Gago-Veiga, A. B., Garcia-Azorin, D., Telleria, J. J., Guerrero, A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734474/ https://www.ncbi.nlm.nih.gov/pubmed/31014225 http://dx.doi.org/10.1186/s10194-019-0989-9 |
Ejemplares similares
-
Prediction of patient's response to OnabotulinumtoxinA treatment for migraine
por: Parrales Bravo, Franklin, et al.
Publicado: (2019) -
Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown
por: Gonzalez-Martinez, Alicia, et al.
Publicado: (2021) -
Cognitive effects of onabotulinumtoxinA in chronic migraine
por: Ho, Susan, et al.
Publicado: (2020) -
OnabotulinumtoxinA: Still the Present for Chronic Migraine
por: Baraldi, Carlo, et al.
Publicado: (2023) -
EHMTI-0105. CGRP and VIP levels as predictors of efficacy of onabotulinumtoxin type A in chronic migraine
por: Cernuda-Morollón, E, et al.
Publicado: (2014)